Literature DB >> 15498467

A rare event of insertion polymorphism of a HERV-K LTR in the human genome.

I Mamedov1, Y Lebedev, G Hunsmann, E Khusnutdinova, E Sverdlov.   

Abstract

Human endogenous retroviruses (HERVs), which constitute a significant part of the human genome, might have a serious impact on primate evolution. Over a hundred insertions of HERV-K(HML-2) family members distinguish the human genome from other primate genomes. However, only three cases of insertion polymorphisms have been reported so far, all for endogenous HERV-K proviruses. This suggests that some retroviral integrations occurred rather recently in human genome evolution. In this report, we describe a very rare case of true insertion polymorphism of a solitary HERV-K LTR in the human genome. Distribution of the LTR-containing allele was tested in 5 Africans and 83 individuals from three Russian populations. The allele frequency appeared to be relatively high in populations of both European and Asian origin. The detected polymorphic LTR could be a useful molecular genetic marker of the corresponding genomic region.

Entities:  

Mesh:

Year:  2004        PMID: 15498467     DOI: 10.1016/j.ygeno.2004.04.010

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  At least 50% of human-specific HERV-K (HML-2) long terminal repeats serve in vivo as active promoters for host nonrepetitive DNA transcription.

Authors:  Anton Buzdin; Elena Kovalskaya-Alexandrova; Elena Gogvadze; Eugene Sverdlov
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

2.  A new set of markers for human identification based on 32 polymorphic Alu insertions.

Authors:  Ilgar Z Mamedov; Irina A Shagina; Marya A Kurnikova; Sergey N Novozhilov; Dmitry A Shagin; Yury B Lebedev
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

3.  Genome-wide amplification of proviral sequences reveals new polymorphic HERV-K(HML-2) proviruses in humans and chimpanzees that are absent from genome assemblies.

Authors:  Catriona M Macfarlane; Richard M Badge
Journal:  Retrovirology       Date:  2015-04-28       Impact factor: 4.602

4.  Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity.

Authors:  Robert Belshaw; Anna L A Dawson; John Woolven-Allen; Joanna Redding; Austin Burt; Michael Tristem
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  Molecular functions of human endogenous retroviruses in health and disease.

Authors:  Maria Suntsova; Andrew Garazha; Alena Ivanova; Dmitry Kaminsky; Alex Zhavoronkov; Anton Buzdin
Journal:  Cell Mol Life Sci       Date:  2015-06-18       Impact factor: 9.261

6.  Ancient retroviral insertions among human populations.

Authors:  Rene J Herrera; Robert K Lowery; Abraham Alfonso; John F McDonald; Javier R Luis
Journal:  J Hum Genet       Date:  2006-03-04       Impact factor: 3.172

7.  Detection of HERV-K6 and HERV-K11 transpositions in the human genome.

Authors:  Buket Cakmak Guner; Elif Karlik; Sevgi Marakli; Nermin Gozukirmizi
Journal:  Biomed Rep       Date:  2018-05-14

8.  Human-specific modulation of transcriptional activity provided by endogenous retroviral insertions.

Authors:  Elena Gogvadze; Elena Stukacheva; Anton Buzdin; Eugene Sverdlov
Journal:  J Virol       Date:  2009-04-01       Impact factor: 5.103

9.  Whole-genome experimental identification of insertion/deletion polymorphisms of interspersed repeats by a new general approach.

Authors:  Ilgar Z Mamedov; Elena S Arzumanyan; Anna L Amosova; Yuri B Lebedev; Eugene D Sverdlov
Journal:  Nucleic Acids Res       Date:  2005-01-26       Impact factor: 16.971

10.  New bioinformatic tool for quick identification of functionally relevant endogenous retroviral inserts in human genome.

Authors:  Andrew Garazha; Alena Ivanova; Maria Suntsova; Galina Malakhova; Sergey Roumiantsev; Alex Zhavoronkov; Anton Buzdin
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.